HENNIGSDORF, Germany, Aug. 19, 2026 /PRNewswire/ -- Over the coming months, SphingoTec will be present at a series of leading conferences in diagnostics and critical care medicine. These engagements reflect the company's ongoing commitment to advancing biomarker-driven solutions that support earlier and more precise clinical decision-making in acute and critical care settings.
Read more at prnewswire.comSphingoTec to Engage with Clinical and Industry Partners at Major 2026 Conferences
Barchart·08/19/2026 03:20:00
语音播报
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.